Noked Israel’s Elevance Health ELV Stock Holding History

Noked Israel’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,400	Closed	-$423K	–	29
2019 Q4	$423K	Buy	+1,400	New	+$385K	0.47%	18
2019 Q3	–	Sell	-1,000	Closed	-$282K	–	65
2019 Q2	$282K	Sell	1,000 -1,000	-50%	-$273K	0.35%	55
2019 Q1	$574K	Sell	2,000 -1,000	-33%	-$289K	0.6%	27
2018 Q4	$788K	Buy	+3,000	New	+$825K	0.66%	20

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Noked Israel's ELV Position: Q1 2020 in Review

Noked Israel sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 1,400 shares — an estimated $423K sold.

Noked Israel first reported a position in ELV in Q4 2018 and held it in 4 quarters. The position peaked at $788K in Q4 2018. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

Noked Israel reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
Noked Israel sold 1,400 Elevance Health shares in Q1 2020, an estimated $423K.
Noked Israel first reported a position in Elevance Health in Q4 2018 and held it in 4 quarters.
Noked Israel's Elevance Health position peaked at $788K in Q4 2018.
1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Noked Israel's 13F filing for Q1 2020, filed 26 May 2020.